Harnessing natural killer cells for the treatment of ovarian cancer.

Hoogstad-van Evert, Janneke S; Bekkers, Ruud; Ottevanger, Nelleke; Jansen, Joop H; Massuger, Leon; Dolstra, Harry

Hoogstad-van Evert, Janneke S; Bekkers, Ruud; Ottevanger, Nelleke; Jansen, Joop H; Massuger, Leon; Dolstra, Harry.

Afiliação

Hoogstad-van Evert JS; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Obstetrics and Gynecology, Amphia Hospital, Breda, the Nethe
Bekkers R; Department of Obstetrics and Gynecology, Catharina Ziekenhuis, Eindhoven, the Netherlands; GROW school for oncology and developmental biology, Maastricht University Medical Centre, the Netherlands.
Ottevanger N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
Jansen JH; Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands.
Massuger L; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands.
Dolstra H; Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands.

Gynecol Oncol ; 157(3): 810-816, 2020 06.

Article em En | MEDLINE | ID: mdl-32268953

Assuntos

Imunoterapia/métodos; Células Matadoras Naturais/transplante; Neoplasias Ovarianas/terapia; Feminino; Humanos

Palavras-chave

Immunotherapy; Natural killer cells; Ovarian cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Células Matadoras Naturais / Imunoterapia Tipo de estudo: Systematic_reviews Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google